Cowen analyst Phil Nadeau weighed in on Editas Medicine (NASDAQ: EDIT) after the company announced that President and CEO Katrine ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE